
Farley J. Abad
Examiner (ID: 14201, Phone: (571)270-3425 , Office: P/2181 )
| Most Active Art Unit | 2181 |
| Art Unit(s) | 2181 |
| Total Applications | 1076 |
| Issued Applications | 864 |
| Pending Applications | 101 |
| Abandoned Applications | 140 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18058003
[patent_doc_number] => 20220389089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => ANTI-IL-27 ANTIBODIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/738927
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58317
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738927
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/738927 | ANTI-IL-27 ANTIBODIES AND USES THEREOF | May 5, 2022 | Pending |
Array
(
[id] => 17243437
[patent_doc_number] => 20210363180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => CHARGED DEPTH FILTRATION OF ANTIGEN- BINDING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/386692
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17386692
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/386692 | CHARGED DEPTH FILTRATION OF ANTIGEN- BINDING PROTEINS | Jul 27, 2021 | Pending |
Array
(
[id] => 17243437
[patent_doc_number] => 20210363180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-25
[patent_title] => CHARGED DEPTH FILTRATION OF ANTIGEN- BINDING PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/386692
[patent_app_country] => US
[patent_app_date] => 2021-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15519
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17386692
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/386692 | CHARGED DEPTH FILTRATION OF ANTIGEN- BINDING PROTEINS | Jul 27, 2021 | Pending |
Array
(
[id] => 17670953
[patent_doc_number] => 20220184120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-16
[patent_title] => ANTI-VARIABLE MUC1* ANTIBODIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/373609
[patent_app_country] => US
[patent_app_date] => 2021-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -61
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373609
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/373609 | ANTI-VARIABLE MUC1* ANTIBODIES AND USES THEREOF | Jul 11, 2021 | Pending |
| 16/933354 | THERAPEUTIC DENDRIMER | Jul 19, 2020 | Abandoned |
Array
(
[id] => 16266436
[patent_doc_number] => 20200267923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => TOMATO VARIETY NUN 00300 TOP
[patent_app_type] => utility
[patent_app_number] => 16/868263
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868263
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/868263 | TOMATO VARIETY NUN 00300 TOP | May 5, 2020 | Abandoned |
Array
(
[id] => 16251305
[patent_doc_number] => 20200260679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => TOMATO VARIETY NUN 00298 TOP
[patent_app_type] => utility
[patent_app_number] => 16/868222
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868222
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/868222 | TOMATO VARIETY NUN 00298 TOP | May 5, 2020 | Abandoned |
Array
(
[id] => 16251306
[patent_doc_number] => 20200260680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => TOMATO VARIETY NUN 00299 TOP
[patent_app_type] => utility
[patent_app_number] => 16/868249
[patent_app_country] => US
[patent_app_date] => 2020-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16868249
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/868249 | TOMATO VARIETY NUN 00299 TOP | May 5, 2020 | Abandoned |
Array
(
[id] => 16557234
[patent_doc_number] => 20210002382
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => ANTIGEN BINDING MOLECULES WITH INCREASED FC RECEPTOR BINDING AFFINITY AND EFFECTOR FUNCTION
[patent_app_type] => utility
[patent_app_number] => 16/787936
[patent_app_country] => US
[patent_app_date] => 2020-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29107
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16787936
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/787936 | ANTIGEN BINDING MOLECULES WITH INCREASED FC RECEPTOR BINDING AFFINITY AND EFFECTOR FUNCTION | Feb 10, 2020 | Abandoned |
Array
(
[id] => 16111603
[patent_doc_number] => 20200207824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-02
[patent_title] => T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/741202
[patent_app_country] => US
[patent_app_date] => 2020-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16741202
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/741202 | T-CELL MODULATORY MULTIMERIC POLYPEPTIDES AND METHODS OF USE THEREOF | Jan 12, 2020 | Abandoned |
Array
(
[id] => 15590367
[patent_doc_number] => 20200071718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-05
[patent_title] => RNA-TARGETING FUSION PROTEIN COMPOSITIONS AND METHODS FOR USE
[patent_app_type] => utility
[patent_app_number] => 16/434689
[patent_app_country] => US
[patent_app_date] => 2019-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16434689
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/434689 | RNA-TARGETING FUSION PROTEIN COMPOSITIONS AND METHODS FOR USE | Jun 6, 2019 | Abandoned |
Array
(
[id] => 15496347
[patent_doc_number] => 20200048362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 16/279113
[patent_app_country] => US
[patent_app_date] => 2019-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27106
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16279113
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/279113 | METHODS OF TREATMENT USING ANTI-ERBB ANTIBODY-MAYTANSINOID CONJUGATES | Feb 18, 2019 | Abandoned |
Array
(
[id] => 9134419
[patent_doc_number] => 20130295133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'RECOMBINANT VIRUS EXPRESSING FOREIGN DNA ENCODING FELINE CD80, FELINE CD86, FELINE CD28, OR FELINE CTLA-4 AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/650553
[patent_app_country] => US
[patent_app_date] => 2012-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 46853
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13650553
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/650553 | RECOMBINANT VIRUS EXPRESSING FOREIGN DNA ENCODING FELINE CD80, FELINE CD86, FELINE CD28, OR FELINE CTLA-4 AND USES THEREOF | Oct 11, 2012 | Abandoned |
Array
(
[id] => 8829310
[patent_doc_number] => 20130130355
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-23
[patent_title] => 'METHOD AND SYSTEM OF PARTICLE-PHAGE EPITOPE COMPLEX'
[patent_app_type] => utility
[patent_app_number] => 13/631389
[patent_app_country] => US
[patent_app_date] => 2012-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 28357
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 37
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13631389
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/631389 | METHOD AND SYSTEM OF PARTICLE-PHAGE EPITOPE COMPLEX | Sep 27, 2012 | Abandoned |
Array
(
[id] => 8697282
[patent_doc_number] => 20130059291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING DENGUE VIRUS'
[patent_app_type] => utility
[patent_app_number] => 13/587087
[patent_app_country] => US
[patent_app_date] => 2012-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3534
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13587087
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/587087 | COMPOSITIONS AND METHODS FOR IDENTIFYING DENGUE VIRUS | Aug 15, 2012 | Abandoned |
Array
(
[id] => 8904117
[patent_doc_number] => 20130171620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-04
[patent_title] => 'VIRAL VARIANTS AND METHODS FOR DETECTING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/547392
[patent_app_country] => US
[patent_app_date] => 2012-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7788
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13547392
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/547392 | VIRAL VARIANTS AND METHODS FOR DETECTING SAME | Jul 11, 2012 | Abandoned |
Array
(
[id] => 8733044
[patent_doc_number] => 20130078613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'Selection of HCV Treatment'
[patent_app_type] => utility
[patent_app_number] => 13/433571
[patent_app_country] => US
[patent_app_date] => 2012-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5610
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13433571
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/433571 | Selection of HCV Treatment | Mar 28, 2012 | Abandoned |
Array
(
[id] => 8289356
[patent_doc_number] => 20120177684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'PAPILLOMAVIRUS VACCINE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/423847
[patent_app_country] => US
[patent_app_date] => 2012-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12922
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13423847
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/423847 | PAPILLOMAVIRUS VACCINE COMPOSITIONS | Mar 18, 2012 | Abandoned |
Array
(
[id] => 9148386
[patent_doc_number] => 20130302909
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-14
[patent_title] => 'ASSESSMENT OF IGF-1 LEVELS IN HIV-INFECTED SUBJECTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/979630
[patent_app_country] => US
[patent_app_date] => 2012-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11921
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979630
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/979630 | ASSESSMENT OF IGF-1 LEVELS IN HIV-INFECTED SUBJECTS AND USES THEREOF | Jan 10, 2012 | Abandoned |
Array
(
[id] => 8138615
[patent_doc_number] => 20120093857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'Vaccination and Immunotherapy as New Therapeutic Modalities in the Treatment of Glaucoma'
[patent_app_type] => utility
[patent_app_number] => 13/324955
[patent_app_country] => US
[patent_app_date] => 2011-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5228
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20120093857.pdf
[firstpage_image] =>[orig_patent_app_number] => 13324955
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/324955 | Vaccination and Immunotherapy as New Therapeutic Modalities in the Treatment of Glaucoma | Dec 12, 2011 | Abandoned |